Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Bismuth subnitrate, heavy
Cross Vetpharm Group Limited
QG52X
Bismuth subnitrate, heavy
2.6 g/syringe
Intramammary suspension
LM: Licensed Merchant as defined in relevant national legislation
Cattle
VARIOUS PRODUCTS FOR TEATS AND UDDER
Miscellaneous
Authorised
2015-01-30
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Mastiseal 2.6 g Intramammary Suspension for Cattle, Dry Cow. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Intramammary suspension. Greyish white, smooth oily suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (dairy cattle at the end of lactation). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The veterinary medicinal product is indicated for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of subclinical mastitis in cows at calving, and of clinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving). It is recommended that the veterinary medicinal product be used as part of a herd approach to dry cow management and mastitis control. 4.3 CONTRAINDICATIONS Do not use in the lactating cow. Do not use in cases of known hypersensitivity to the active substance or any of the excipients. Do not use in cows with suspected or confirmed mastitis at drying off. See section 4.5. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each 4 g intramammary syringe contains: Active substance Bismuth subnitrate, heavy 2.6 g For the full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _3_ _0_ _/_ _0_ _1_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _6_ _2_ _7_ _0_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTI Read the complete document